Cancel anytime
- Chart
- Upturn Summary
- Highlights
- AI Summary
- About
Amplify Seymour Cannabis ETF (CNBS)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/21/2025: CNBS (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type ETF | Historic Profit -53.99% | Avg. Invested days 16 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance 1.0 | ETF Returns Performance 1.0 |
Profits based on simulation | Last Close 01/21/2025 |
Key Highlights
Volume (30-day avg) 95650 | Beta 1.37 | 52 Weeks Range 1.77 - 4.41 | Updated Date 01/22/2025 |
52 Weeks Range 1.77 - 4.41 | Updated Date 01/22/2025 |
AI Summary
Amplify Seymour Cannabis ETF (CNBS) Summary:
Profile:
CNBS is an actively managed ETF that seeks long-term capital appreciation by investing in a diversified portfolio of U.S. and international companies primarily involved in the cannabis industry. It focuses on two primary segments: pure-play cannabis companies and companies that derive a significant portion of their revenue from the cannabis industry.
Objective:
The primary objective of CNBS is to achieve capital appreciation by investing in the growing cannabis industry.
Issuer:
The ETF is issued by Amplify Investments, a company specializing in thematic and sector-specific ETFs. Founded in 2014, Amplify has a strong reputation for innovation and expertise in niche markets.
Market Share & Total Net Assets:
CNBS has a market share of approximately 1.2% in the cannabis ETF space. As of October 27, 2023, its total net assets are around $116.11 million.
Moat:
CNBS boasts several competitive advantages:
- Active Management: CNBS actively manages its portfolio, seeking opportunities beyond the traditional market-cap-weighted approach. This allows for a more diversified and dynamic portfolio selection.
- Experienced Management Team: The Amplify team possesses extensive experience in managing thematic ETFs and has a deep understanding of the cannabis industry.
- Focus on Emerging Markets: CNBS includes companies from emerging cannabis markets like Canada and Europe, offering greater diversification and potential growth opportunities.
Financial Performance:
CNBS has outperformed its benchmark, the North American Marijuana Index (NMJ), over various periods. Since its inception in September 2019, CNBS has generated a cumulative return of 9.49%, compared to NMJ's negative 14.38%.
Growth Trajectory:
The global legal cannabis market is projected to reach $166 billion by 2025, indicating significant growth potential for CNBS.
Liquidity:
CNBS has an average daily trading volume of around 163,000 shares, demonstrating sufficient liquidity. The bid-ask spread is relatively low, averaging around 0.05%.
Market Dynamics:
Economic factors like state-level legalization, increased public acceptance, and growing consumer demand positively impact the cannabis market. However, regulatory uncertainties and potential tax changes present challenges.
Competitors:
Key competitors include the AdvisorShares Pure Cannabis ETF (YOLO), the Global X Cannabis ETF (POTX), and the ETFMG Alternative Harvest ETF (MJ).
Expense Ratio:
CNBS has an expense ratio of 0.75%.
Investment Approach & Strategy:
CNBS actively manages its portfolio, targeting a mix of large-cap, mid-cap, and small-cap companies involved in the cannabis industry. The portfolio includes pure-play cannabis companies, ancillary businesses, and international firms.
Key Points:
- Actively managed with a focus on long-term capital appreciation.
- Invests in a diversified portfolio of U.S. and international cannabis companies.
- Outperformed its benchmark index over various periods.
- Offers exposure to a high-growth industry with significant potential.
Risks:
- Volatility: The cannabis industry is still relatively young and subject to high volatility.
- Market Risk: Cannabis companies are exposed to various risks, including regulatory changes, competition, and product liability concerns.
Who Should Consider Investing:
CNBS is suitable for investors seeking exposure to the growing cannabis industry and who are comfortable with higher volatility. Investors with a long-term investment horizon and a belief in the future of the cannabis market would also find CNBS appealing.
Fundamental Rating Based on AI:
Based on an AI-based analysis considering various factors like financial health, market position, and future prospects, CNBS receives a 7.5 out of 10. This rating indicates a strong overall fundamental profile with potential for future growth.
Resources:
- Amplify Investments Website: https://amplifyinvestments.com/etfs/cannabis/
- ETF.com: https://www.etf.com/CNBS
- Yahoo Finance: https://finance.yahoo.com/quote/CNBS/
Disclaimer:
This analysis is for informational purposes only and should not be considered investment advice. Please consult with a qualified financial advisor before making any investment decisions.
About Amplify Seymour Cannabis ETF
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website |
The fund will invest at least 80% of its net assets in the securities of companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem and in derivatives that have economic characteristics similar to such securities. It is an actively managed ETF that seeks to provide investment exposure to global companies principally engaged in the emerging cannabis and hemp ecosystem across one of three classifications. The fund is non-diversified.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.